Lv0
0 积分 2025-09-23 加入
Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer
4个月前
已完结
Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma
5个月前
已完结
Sarcomatoid Intrahepatic Cholangiocarcinoma
5个月前
已关闭
Acquired ALK and RET Gene Fusions as Mechanisms of Resistance to Osimertinib in EGFR-Mutant Lung Cancers
5个月前
已完结
Acquired ALK and RET Gene Fusions as Mechanisms of Resistance to Osimertinib in EGFR -Mutant Lung Cancers
5个月前
已完结
Circulating Tumor DNA Assessment to Predict Risk of Recurrence after Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma
5个月前
已完结
Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR+ NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer
5个月前
已完结
Acquired EML4-ALK fusion and EGFR C797S in cis mutation as resistance mechanisms to osimertinib in a non-small cell lung cancer patient with EGFR L858R/T790M
6个月前
已完结
Clinical application of circulating tumour DNA in colorectal cancer
11个月前
已完结
Minimal residual disease in colorectal cancer. Tumor-informed versus tumor-agnostic approaches: unraveling the optimal strategy
11个月前
已完结
皖公网安备34019202002308
